Sex-Specific Changes in Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Gene Expression and Enzyme Activity at Birth and Over the First Year of Life
- PMID: 26243544
- PMCID: PMC5933173
- DOI: 10.1177/1933719115597760
Sex-Specific Changes in Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Gene Expression and Enzyme Activity at Birth and Over the First Year of Life
Abstract
Objective: Angiotensin-converting enzyme (ACE) and angiotensin-converting enzyme 2 (ACE2) are key enzymes of the renin-angiotensin system. We investigated developmental changes in renal ACE and ACE2 gene expression and activity in both male and female sheep.
Methods: Three groups of sheep (fetus, newborn, and adult) were used. Renal ACE and ACE2 activities, messenger RNA (mRNA), and protein expression were studied.
Results: Renal ACE and ACE2 activities increased at 1 year in males, while there were no changes throughout development in females. Renal ACE and ACE2 mRNA and protein showed no sex differences but increased by 1 year of age.
Conclusion: There are sex-related differences in the development of renal-converting enzyme activities that may have functional implications in terms of the regulation of blood pressure and renal function in men and women. The difference in the patterns of gene expression and enzyme activity indicates that changes in gene expression may not accurately reflect changes in activity.
Keywords: angiotensin-converting enzyme; angiotensin-converting enzyme 2; kidney; renin–angiotensin system; sex.
© The Author(s) 2015.
Conflict of interest statement
Figures







Similar articles
-
Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio.Endocrinology. 2007 May;148(5):2453-7. doi: 10.1210/en.2006-1287. Epub 2007 Feb 15. Endocrinology. 2007. PMID: 17303661
-
Relationship between renal injury and the antagonistic roles of angiotensin-converting enzyme (ACE) and ACE2.Genet Mol Res. 2014 Apr 3;13(2):2333-42. doi: 10.4238/2014.April.3.5. Genet Mol Res. 2014. PMID: 24781988
-
Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia-reperfusion model.Peptides. 2012 Jul;36(1):60-70. doi: 10.1016/j.peptides.2012.04.024. Epub 2012 May 8. Peptides. 2012. PMID: 22580272
-
Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in?Clin Exp Pharmacol Physiol. 2013 Aug;40(8):551-9. doi: 10.1111/1440-1681.12069. Clin Exp Pharmacol Physiol. 2013. PMID: 23432153 Review.
-
Intrarenal Angiotensin-Converting Enzyme: the Old and the New.Curr Hypertens Rep. 2017 Sep 19;19(10):80. doi: 10.1007/s11906-017-0778-2. Curr Hypertens Rep. 2017. PMID: 28929450 Free PMC article. Review.
Cited by
-
Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.Molecules. 2021 May 14;26(10):2917. doi: 10.3390/molecules26102917. Molecules. 2021. PMID: 34068970 Free PMC article. Review.
-
Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H296-H304. doi: 10.1152/ajpheart.00755.2020. Epub 2020 Dec 4. Am J Physiol Heart Circ Physiol. 2021. PMID: 33275517 Free PMC article. Review.
-
SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.FASEB J. 2020 Nov;34(11):14103-14119. doi: 10.1096/fj.202001394RR. Epub 2020 Sep 23. FASEB J. 2020. PMID: 32965736 Free PMC article. Review.
-
Chronic kidney disease in the pathogenesis of acute ischemic stroke.J Cereb Blood Flow Metab. 2019 Oct;39(10):1893-1905. doi: 10.1177/0271678X19866733. Epub 2019 Aug 1. J Cereb Blood Flow Metab. 2019. PMID: 31366298 Free PMC article. Review.
-
Omeprazole use and risk of chronic kidney disease evolution.PLoS One. 2020 Mar 4;15(3):e0229344. doi: 10.1371/journal.pone.0229344. eCollection 2020. PLoS One. 2020. PMID: 32130255 Free PMC article.
References
-
- Givertz MM. Manipulation of the renin–angiotensin system. Circulation. 2001;104(5):E14–E18. - PubMed
-
- Timmermans PB, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45(2):205–251. - PubMed
-
- Peach MJ. Molecular actions of angiotensin. Biochem Pharmacol. 1981;30(20):2745–2751. - PubMed
-
- Csikos T, Gallinat S, Unger T. Extrarenal aspects of angiotensin II function. Eur J Endocrinol. 1997;136(4):349–358. - PubMed
-
- Bottari SP, De GM, Steckelings UM, Levens NR. Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol. 1993;14(2):123–171. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous